Skip to main content
SpringerLink
Log in

Neonatal Metabolism of surfactant Phosphatidylcholine: Therapeutic Implications

  • Chapter
Intensive Care in Childhood

Part of the book series: Update in Intensive Care and Emergency Medicine ((UICM,volume 25))

  • 154 Accesses

Abstract

Neonatal respiratory distress syndrome (RDS), also known as hyaline membrane disease, is an important cause of neonatal and infant mortality. Together with congenital malformations, it is the leading cause of death in preterm infants and responsible for serious morbidity in survivors, associated with high costs to society.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Avery ME, Mead J (1959) Surface properties in relation to atelectasis and hyaline membrane disease. Am J Dis Child 97:517–523.

    CAS  Google Scholar 

  2. Jobe AH (1993) Pulmonary surfactant therapy. N Engl J Med 328:861–868.

    Article  PubMed  CAS  Google Scholar 

  3. Crowley P, Chalmers I, Keirse MJ (1990) The effect of corticosteroid administration before preterm delivery: an overview of the evidence from controlled trials. Br J Obstet Gynaecol 97:11–25.

    Article  PubMed  CAS  Google Scholar 

  4. The OSIRIS collaborative group (1992) Early versus delayed neonatal administration of synthetic surfactant-the judgment of OSIRIS. Lancet 340:1363–1369.

    Article  Google Scholar 

  5. Ballard RA, Ballard PL (1992) Prevention of neonatal respiratory distress syndrome by pharmacological methods. In: Robertson B, Van Golde LGM, Batenburg JJ, eds. Pulmonary surfactant: from molecular biology to clinical practice. Amsterdam: Elsevier, pp 539–560.

    Google Scholar 

  6. Post M, Smith BT (1992) Hormonal control of surfactant metabolism. In: Robertson B, van Golde LMG, Batenburg JJ, eds. Pulmonary surfactant: from molecular biology to clinical practice. Amsterdam: Elsevier, pp 379–424.

    Google Scholar 

  7. Benediktsson R, Lindsay RS, Noble J, Seckl JR, Edwards CRW (1993) Glucocorticoid exposure in utero: new model for adult hypertension. Lancet 341:339–341.

    Article  PubMed  CAS  Google Scholar 

  8. Jobe AH, Rider ED (1992) Catabolism and recycling of surfactant. In: Robertson B, van Golde LMG, Batenburg JJ, eds. Pulmonary surfactant: from molecular biology to clinical practice. Amsterdam: Elsevier, pp 313–337.

    Google Scholar 

  9. Post M, Van Golde LMG (1988) Metabolic and developmental aspects of pulmonary surfactant systems. Biochim Biophys Acta 947:249–286.

    PubMed  CAS  Google Scholar 

  10. Zimmermann LJ, Hogan M, Carlson KS, Smith BT, Post M (1993) Regulation of phosphatidylcholine synthesis in fetal type II cells by CTP:phosphocholine cytidylyltransferase. Am J Physiol 264: L575-L580.

    PubMed  CAS  Google Scholar 

  11. Feldman DA, Weinhold PA (1987) CTP:phosphorylcholine cytidylyltransferase from rat liver. Isolation and characterization of the catalytic subunit. J Biol Chem 262:9075–9081.

    PubMed  CAS  Google Scholar 

  12. Kalmar GB, Kay RJ, Lachance A, Aebersold R, Cornell RB (1990) Cloning and expression of rat liver CTP: phosphocholine cytidylyltransferase: an amphipathic protein that controls phosphatidylcholine synthesis. Proc Natl Acad Sci USA 87:6029–6033.

    Article  PubMed  CAS  Google Scholar 

  13. Hogan M, Zimmermann LJ, Wang J, Kuliszewski M, Liu J, Post M (1994) Increased expression of CTP:phosphocholine cytidylyltransferase in maturing type II cells. Am J Physiol 267:L25-L32.

    PubMed  CAS  Google Scholar 

  14. Zimmermann LJI (1995) The regulation of CTP:phosphocholine cytidylyltransferase in fetal type II cells [PhD thesis]. Erasmus University Rotterdam, The Netherlands, 277 p.

    Google Scholar 

  15. Rooney SA (1989) Fatty acid biosynthesis in developing fetal lung. Am J Physiol 257:L195-L201.

    PubMed  CAS  Google Scholar 

  16. Avery ME (1995) Historical overview of antenatal steroid use. Pediatr 95:133–135.

    CAS  Google Scholar 

  17. Ryan CA, Finer NN (1995) Antenatal corticosteroid therapy to prevent respiratory distress syndrome. J Pediatr 126:317–319.

    Article  PubMed  CAS  Google Scholar 

  18. Morales WJ, O’Brien WF, Angel JL, Knüppel RA, Sawai S (1989) Fetal lung maturation: the combined use of corticosteroids and thyrotropin-releasing hormone. Obstet Gynecol 73:111–116.

    PubMed  CAS  Google Scholar 

  19. Ballard RA, Ballard PL, Creasy RK, et al. (1992) Respiratory disease in very-low-birth-weight infants after prenatal thyrotropin-releasing hormone and glucocorticoid. TRH Study Group. Lancet 339:510–515.

    Article  PubMed  CAS  Google Scholar 

  20. ACTOBAT Study Group (1995) Australian collaborative trial of antenatal thyrotropin-releasing hormone (ACTOBAT) for prevention of neonatal respiratory disease. Lancet 345:877–882.

    Article  Google Scholar 

  21. Suen HC, Bloch KD, Donahoe PK (1994) Antenatal glucocorticoid corrects pulmonary immaturity in experimentally induced congenital diaphragmatic hernia in rats. Pediatr Res 35:523–529.

    Article  PubMed  CAS  Google Scholar 

  22. NIH Consensus Conference (1995) Effect of corticosteroids for fetal maturation on perinatal outcomes. JAMA 273:413–418.

    Article  Google Scholar 

  23. Jobe AH, Ikegami M (1993) Surfactant metabolism. Clin Perinatol 20:683–696.

    PubMed  CAS  Google Scholar 

  24. Adams FH, Fujiwara T, Emmanouilides GC, et al. (1970) Lung phospholipid of the human fetus and infants with and without hyaline membrane disease. J Pediatr 77:833.

    Article  PubMed  CAS  Google Scholar 

  25. Hallman M, Merritt TA, Pohjavuori M, Gluck L (1986) Effect of surfactant substitution on lung effluent phospholipids in respiratory distress syndrome: Evaluation of surfactant phospholipid turnover, pool size, and the relationship to severity of respiratory failure. Pediatr Res 20:1228–1235.

    Article  PubMed  CAS  Google Scholar 

  26. Dargaville PA, McDougall PN, South M (1995) Comparison of tracheal aspirate and bron-choalveolar lavage for collection of surfactant specimens in ventilated infants. Appl Car-diopulm Pathophysiol 5:18–19 (abstr)

    Google Scholar 

  27. Hallman M, Merritt TA, Akino T, Bry K (1991) Surfactant protein A, phosphatidylcholine, and surfactant inhibitors in epithelial lining fluid. Am Rev Respir Dis 144:1376–1384.

    PubMed  CAS  Google Scholar 

  28. Hallman M, Merritt TA, Bry K (1994) The fate of exogenous surfactant in neonates with respiratory distress syndrome. [Review]. Clin Pharmacokinet 26:215–232.

    Article  PubMed  CAS  Google Scholar 

  29. Konishi M, Fujiwara T, Nalto T, et al. (1988) Surfactant replacement therapy in neonatal respiratory distress syndrome. A multi-centre, randomized clinical trial: comparison of high-versus low-dose of Surfactant TA. Eur J Pediatr 147:20–25.

    Article  PubMed  CAS  Google Scholar 

  30. Charon A, Taeusch HW, Fitzgibbon C, Smith. GB, Treves ST, Phelps DS (1989) Factors associated with surfactant treatment response in infants with severe respiratory distress syndrome. Pediatr 83:348–354.

    CAS  Google Scholar 

  31. Dunn MS, Shennan AT, Possmayer F (1990) Single-versus multiple-dose surfactant replacement therapy in neonates of 30 to 36 weeks gestation with respiratory distress syndrome. Pediatr 86:564–571.

    CAS  Google Scholar 

  32. Speer CP, Robertson B, Curstedt T, et al. (1992) Randomized European Multicenter Trial of surfactant replacement therapy for severe neonatal respiratory distress syndrome: single versus multiple doses of Curosurf. Pediatr 89:13–20.

    CAS  Google Scholar 

Download references

Authors
  1. L. J. I. Zimmermann
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Dept. of Pediatric Surgery, Pediatric Surgical Intensive Care Unit, Sophia Children’s Hospital, University Hospital Rotterdam, Dr. Molewaterplein 60, NL-3015, GJ Rotterdam, The Netherlands

    Dick Tibboel

  2. Dept. of Pediatrics, Subdivision of Pediatric, Intensive Care, Sophia Children’s Hospital, University Hospital Rotterdam, Dr. Molewaterplein 60, NL-3015, GJ Rotterdam, The Netherlands

    Edwin van der Voort

Rights and permissions

Reprints and permissions

Copyright information

© 1996 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Zimmermann, L.J.I. (1996). Neonatal Metabolism of surfactant Phosphatidylcholine: Therapeutic Implications. In: Tibboel, D., van der Voort, E. (eds) Intensive Care in Childhood. Update in Intensive Care and Emergency Medicine, vol 25. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-80227-0_6

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-80227-0_6

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-80229-4

  • Online ISBN: 978-3-642-80227-0

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation